文献速递肺结节与肺癌

超声内镜技术在肺癌新辅助治疗后纵隔再分期中的诊断准确性:系统评价与Meta分析

Efficacy of Endosonographic Procedures in Mediastinal Restaging of Lung Cancer After Neoadjuvant Therapy: A Systematic Review and Diagnostic Accuracy Meta-Analysis.
PubMed 文献 · Chest · 2018-04-21

该系统评价与诊断准确性Meta分析纳入10项研究共574例III期肺癌新辅助治疗后纵隔再分期患者,评估超声内镜技术(EUS、EBUS或两者联合)的准确性。汇总敏感度为67%(95%CI 56-77),特异度为99%(95%CI 89-100),诊断OR为157,阳性似然比52.0,阴性似然比0.33,未报告并发症。结论认为超声内镜技术安全且特异度高。

要点

  • 超声内镜用于肺癌诱导治疗后纵隔再分期特异度达99%,阳性结果可高度确信残留纵隔病变。
  • 汇总敏感度67%,阴性结果不能除外纵隔残留病灶,需结合手术病理确认。
  • 纳入研究未报告并发症,提示该技术安全性良好。

核心结论

  • 超声内镜技术(EUS、EBUS或两者联合)在肺癌新辅助治疗后纵隔再分期中安全且高度特异。

研究设计与样本

  • 系统评价与诊断准确性Meta分析,检索PubMed和Embase数据库,纳入10项研究共574例III期肺癌诱导治疗后纵隔再分期患者。
  • 采用QUADAS-2工具评估纳入研究质量,采用双变量模型汇总敏感度、特异度、似然比和诊断OR。

主要发现

  • 汇总敏感度为67%(95%CI 56-77),特异度为99%(95%CI 89-100),诊断OR为157。
  • 汇总阳性似然比为52.0,阴性似然比为0.33。
  • 未报告并发症。
  • 敏感度存在显著异质性,敏感度分析和Meta回归提示研究设计、偏倚风险及N2病变患病率与异质性相关。
  • 漏斗图提示发表偏倚,但统计学检验未证实。

临床怎么用

  • 超声内镜可用于肺癌新辅助治疗后纵隔再分期,阳性结果高度提示纵隔残留病变。
  • 阴性结果因敏感度有限不能排除纵隔残留,需结合手术病理等进一步评估。

局限性

  • 敏感度存在显著异质性,部分与研究设计和偏倚风险相关。
  • 漏斗图提示可能存在发表偏倚。
  • 纳入研究数量有限(10项,574例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal modality for restaging the mediastinum following neoadjuvant therapy for lung cancer remains unclear. Surgical methods are currently considered the reference standard. The present study evaluates the role of endosonographic techniques for mediastinal restaging in lung cancer. METHODS: A systematic review of PubMed and Embase databases was performed to identify studies using endoscopic ultrasound, endobronchial ultrasound, or a combination of the two for mediastinal restaging following induction therapy for stage III lung cancer. The quality of the included studies was assessed by using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. The accuracy of endosonography was analyzed by calculating the sensitivity, specificity, likelihood ratio, and diagnostic OR for each study and pooling the results by using a bivariate model. Heterogeneity and publication bias were assessed. Potential causes of heterogeneity were explored by using sensitivity analysis and meta-regression. RESULTS: Ten studies (N = 574) were included. The pooled sensitivity, specificity, diagnostic OR, and positive and negative likelihood ratios were 67% (95% CI, 56-77), 99% (95% CI, 89-100), 157, 52.0, and 0.33, respectively. No complications were reported. Significant heterogeneity was observed for the outcome of sensitivity. Sensitivity analysis identified several factors accounting for heterogeneity, including study design and risk of bias. The sensitivity of the endosonographic procedure was also linked to the prevalence of N2 disease on meta-regression. Funnel plot showed publication bias, but this finding was not evident on statistical tests. CONCLUSIONS: Endosonographic procedures are safe and highly specific in mediastinal restaging of lung cancer.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Muthu V, Sehgal IS, Dhooria S, et al. Efficacy of Endosonographic Procedures in Mediastinal Restaging of Lung Cancer After Neoadjuvant Therapy: A Systematic Review and Diagnostic Accuracy Meta-Analysis. Chest. 2018. PMID: 29684314. doi:10.1016/j.chest.2018.04.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。